Chen Ke, Pan Yu, Wang Yi-Fan, Zheng Xue-Yong, Liang Xiao, Yu Hong, Cai Xiu-Jun
Department of General Surgery, Institute of Minimally Invasive Surgery, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
J Laparoendosc Adv Surg Tech A. 2019 Apr;29(4):503-512. doi: 10.1089/lap.2018.0480. Epub 2019 Jan 9.
The application of laparoscopic hepatectomy is gaining momentum. However, the safety and efficacy of laparoscopic right hepatectomy (LRH) on hepatocellular carcinoma (HCC) are yet to be adequately evaluated. We aimed to assess the surgical and oncological outcomes of LRH for HCC by comparing it with open right hepatectomy (ORH).
Data of patients who underwent hepatectomy for HCC from May 2007 to January 2018 in our hospital were obtained. Baseline characteristics, postoperative recovery, and survival outcomes were compared. One-to-one propensity score matching (PSM) was used to minimize selection biases by balancing factors, including age, sex, preoperative therapy, tumor size, and pattern.
The original cohort included 109 patients (LRH, 41 patients; ORH, 68 patients). Of the 41 patients who underwent LRH, 8 patients (19.5%) required conversion to laparotomy. The overall morbidity was 19.5%, and no mortality in LRH was noted. After PSM, LRH was associated with a tendency of prolonged operative time (255.5 ± 93.4 minutes versus 225.9 ± 39.8 minutes, P = .08) and less intraoperative blood loss [300 (100-1200) versus 500 (200-2000) mL, P < .01]. LRH showed up a trend of less overall morbidity without statistical significance (18.4% versus 26.3%, P = .41). Moreover, the 3-year overall and disease-free survival did not differ significantly between the groups during a median follow-up of 19 (3-58) months for the LRH group and 23 (3-97) months for the ORH group.
LRH can be performed as safe and effective as ORH for HCC in regard to both surgical and oncological outcomes. LRH holds the benefit in less intraoperative blood loss and appears to achieve less postoperative morbidity, which could serve as a promising alternative to ORH in selected individuals.
腹腔镜肝切除术的应用正在兴起。然而,腹腔镜右半肝切除术(LRH)治疗肝细胞癌(HCC)的安全性和有效性尚未得到充分评估。我们旨在通过将LRH与开放性右半肝切除术(ORH)进行比较,评估LRH治疗HCC的手术及肿瘤学结局。
获取了2007年5月至2018年1月在我院因HCC接受肝切除术患者的数据。比较了基线特征、术后恢复情况及生存结局。采用一对一倾向评分匹配(PSM)通过平衡年龄、性别、术前治疗、肿瘤大小及类型等因素来最小化选择偏倚。
原始队列包括109例患者(LRH组41例;ORH组68例)。在接受LRH的41例患者中,8例(19.5%)需要转为开腹手术。LRH组总体并发症发生率为19.5%,无死亡病例。PSM后,LRH组手术时间有延长趋势(255.5±93.4分钟对225.9±39.8分钟,P = 0.08),术中出血量较少[300(100 - 1200)对500(200 - 2000)mL,P < 0.01]。LRH组总体并发症发生率有降低趋势但无统计学意义(18.4%对26.3%,P = 0.41)。此外,LRH组中位随访19(3 - 58)个月,ORH组中位随访23(3 - 97)个月,两组3年总生存率和无病生存率差异无统计学意义。
就手术及肿瘤学结局而言,LRH治疗HCC与ORH同样安全有效。LRH具有术中出血量较少的优势,且术后并发症发生率似乎更低,这使其在特定患者中有望成为ORH的替代术式。